Lucintel Newsletter

Business News by Lucintel

Bookmark and Share

Wednesday, August 14, 2024

Lucintel Forecasts Middle Eastern and North African Active Pharmaceutical Ingredient (API) Market to Reach $5 Billion by 2030

According to the recent study the Middle Eastern and North African active pharmaceutical ingredient (API) market is projected to reach an estimated $5 billion by 2030 from $3 billion in 2023 at a CAGR of 5% from 2023 to 2030. Growth in this market is primarily driven by pharmaceutical production and research and development of new drugs.

A more than 150 page report to understand trends, opportunities and forecast in Middle Eastern and North African active pharmaceutical ingredient (API) market by synthesis type (synthetic chemical, biotech and biologics, plant extracts, fermentation, and others), manufacturer type (captive API and merchant API), therapeutic area (cardiology, oncology, neurology, ophthalmology, orthopedics, pulmonology, aliment, anti-inflammatory, and others), product form (liquid API and powder API), molecule type (large molecule and small molecule), and drug type (branded, generic, and over-the-counter).

Lucintel forecasts that synthetic chemical will remain the largest segment over the forecast period due to continuous research and development activities and growing demand of synthetic chemical APIs in therapeutic areas.

Within this market, cardiology will remain the largest therapeutic area segment over the forecast period due to increasing cardiovascular diseases and increase in geriatric population.

Download report by clicking on Middle Eastern and North African active pharmaceutical ingredient (API) market.

Pfizer, Teva Pharmaceutical, GSK, Sun Pharmaceutical, Novartis, Aurobindo, Merck& Co., BASF, Julphar, and AbbVie are the major suppliers in the Middle Eastern and North African active pharmaceutical ingredient (API) providers.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email:
roy.almaguer@lucintel.com
Tel. +1 972.636.5056

Explore Our Latest Publications

Ring Doughnut Market

Stem Cell Research Antibody Market

Lead Counterweight Market

Sheet Molding Compound Market

Indian Composites Market

UK Composites Market

No comments:

Post a Comment